Creating a World Without
Heart Attacks
Introducing a new standard of
precision heart care.
Cleerly's Cardiac Care Pathway is used to precisely identify heart disease in individuals sooner, and guide personalized treatment that helps prevent future heart attacks.
Cleerly yields life and cost-saving insights.
Providers can leverage Cleerly to identify individuals at risk and take preventative steps to avoid future adverse and costly events. Both providers and individuals benefit from Cleerly's non-invasive heart evaluation method that limits unnecessary procedures and tests, and improves quality of life.
Watch how one individual without any symptoms of heart disease was able to prevent a heart attack with Cleerly insights.
![Cleerly heart analysis background image](https://cleerlyhealth.com/hs-fs/hubfs/terry-schemmel-AHA-video-bkgd-03.jpg?width=3840&height=2160&name=terry-schemmel-AHA-video-bkgd-03.jpg)
Explore how you can leverage Cleerly's technology to improve patient outcomes.
The science behind Cleerly.
Cleerly's Cardiac Care Pathway is used to prevent heart attacks and improve clinical outcomes through precision diagnostics and personalized therapy.
"I didn't ever have any symptoms. I didn't have any reason to believe there was anything wrong with my heart. If you have no symptoms and the first symptom you have is a heart attack, how cool would it be to know your risk ahead of time?"
-Terry Schemmel, Cleerly employee
More to explore
3 min read
Catching Plaque Early Guides Personalized Treatment and Tracking of Heart Disease
Oct 18, 2022
3 min read
Cleerly Analysis Offers Critical Insight on Heart Health
Jun 8, 2022
Ready to Learn More?
Schedule a demo with us to explore Cleerly and how you can leverage our non-invasive technology to improve patient heart health outcomes.
Patents
Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.
Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 11,922,627, 11,948,301, 12,023,190, 11,861,833, 11,967,078, 11,832,982, 11,690,586, 11,779,292, 11,730,437, 11,672,497, 11,737,718, 11,751,826, 11,660,058, 11,896,415, 11,751,830, 11,751,829, 11,302,001, 11,308,617, 11,238,587, 11,302,002, 11,321,840, 11,341,644, 11,244,451, 11,288,799, 11,276,170, 11,210,786, 11,232,564, 11,367,190, 11,315,247, 11,969,280, 11,094,060, 11,120,550, 11,120,549, 11,132,796, 11,094,061, 11,113,811, 11,501,436, 11,751,831, 11,642,092, 11,759,161, 11,317,883, 11,350,899, 11,766,230, 11,766,229, and 10,813,612, as well as other patents that are pending.
For additional information, please contact legal@cleerlyhealth.com.